A phase-2 clinical study to determine the efficacy and safety of DepoCyte (cytarabine liposome injection) for the treatment of CNS relapse in adult patients with acute lymphoblastic leukemia or very aggressive lymphoma

Trial Profile

A phase-2 clinical study to determine the efficacy and safety of DepoCyte (cytarabine liposome injection) for the treatment of CNS relapse in adult patients with acute lymphoblastic leukemia or very aggressive lymphoma

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 02 Aug 2016

At a glance

  • Drugs Cytarabine (Primary)
  • Indications Acute lymphoblastic leukaemia; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 May 2008 The expected completion date for this trial is now 1 Jun 2008, according to ClinicalTrials.gov.
    • 29 May 2008 Status changed from recruiting to in progress, reported by ClinicalTrials.gov.
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top